GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » Sale Of Business

HLTRF (HLS Therapeutics) Sale Of Business : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is HLS Therapeutics Sale Of Business?

HLS Therapeutics's sale of business for the three months ended in Sep. 2024 was $0.00 Mil. It means HLS Therapeutics gained $0.00 Mil from selling business. HLS Therapeutics's sale of business for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2024 ), HLS Therapeutics gained the same money from selling business in Sep. 2024 ($0.00 Mil).

HLS Therapeutics Sale Of Business Historical Data

The historical data trend for HLS Therapeutics's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Sale Of Business Chart

HLS Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HLS Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

HLS Therapeutics Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HLS Therapeutics Sale Of Business Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » Sale Of Business
Comparable Companies
XCNQ:AYR.A XCNQ:VREO XCNQ:AAWH.U XCNQ:JUSH TSXV:SBBC TSXV:RX NEOE:CBST XCNQ:IAN XCNQ:GWAY TSXV:ZYUS ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
HLS:Canada
Address
10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W 6L2
Website
https://www.hlstherapeutics.com
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, and the United States, and the Rest of the world.